Metropolis Healthcare Ltd
METROPOLISMetropolis Healthcare Ltd
METROPOLIS
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 53.32 | 7.44 | 0.56% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.01 | 4.70 | 0.78% |
Forecast & Ratings
Detailed Forecastfrom 12 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Metropolis Healthcare is a medical laboratory operator
Investor Presentation
View olderPeers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Narayana Hrudayalaya Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 460.63 | 493.95 | 570.31 | 654.93 | 769.39 | 864.98 | 1,010.04 | 1,261.96 | 1,163.43 | 1,160.67 | ||||||||||
Raw Materials | 128.98 | 124.59 | 135.10 | 145.90 | 173.51 | 204.14 | 252.16 | 276.02 | 253.26 | 862.70 | ||||||||||
| Power & Fuel Cost | 8.15 | 8.06 | 9.12 | 9.99 | 11.00 | 12.49 | 12.00 | 14.73 | 14.43 | |||||||||||
| Employee Cost | 98.07 | 108.18 | 127.70 | 147.37 | 176.21 | 190.16 | 198.64 | 233.17 | 252.73 | |||||||||||
| Selling & Administrative Expenses | 82.67 | 87.03 | 101.29 | 90.92 | 106.87 | 165.77 | 185.28 | 311.76 | 289.77 | |||||||||||
| Operating & Other expenses | 19.02 | 20.32 | 18.01 | 74.51 | 91.07 | 71.76 | 60.12 | 44.68 | 44.67 | |||||||||||
EBITDA | 123.74 | 145.77 | 179.09 | 186.24 | 210.73 | 220.66 | 301.84 | 381.60 | 308.57 | 297.97 | ||||||||||
| Depreciation/Amortization | 20.52 | 16.64 | 17.23 | 19.02 | 20.07 | 39.27 | 45.94 | 63.22 | 89.22 | 88.86 | ||||||||||
| PBIT | 103.22 | 129.13 | 161.86 | 167.22 | 190.66 | 181.39 | 255.90 | 318.38 | 219.35 | 209.11 | ||||||||||
| Interest & Other Items | 2.16 | 1.60 | 1.94 | 3.54 | 4.12 | 12.65 | 11.56 | 25.02 | 31.85 | 25.25 | ||||||||||
| PBT | 101.06 | 127.53 | 159.92 | 163.68 | 186.54 | 168.74 | 244.34 | 293.36 | 187.50 | 183.86 | ||||||||||
| Taxes & Other Items | 40.09 | 50.73 | 58.26 | 59.45 | 66.40 | 41.41 | 61.22 | 79.16 | 44.62 | 45.58 | ||||||||||
| Net Income | 60.97 | 76.80 | 101.66 | 104.23 | 120.14 | 127.33 | 183.12 | 214.20 | 142.88 | 138.28 | ||||||||||
| EPS | 11.89 | 15.22 | 20.48 | 21.00 | 24.07 | 25.26 | 36.00 | 41.88 | 27.91 | 27.00 | ||||||||||
| DPS | 0.00 | 15.46 | 10.07 | 0.00 | 13.26 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | ||||||||||
| Payout ratio | 0.00 | 1.02 | 0.49 | 0.00 | 0.55 | 0.32 | 0.22 | 0.19 | 0.29 | 0.30 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Metropolis Healthcare Ltd | 51.60 | 7.44 | 0.56% |
| Apollo Hospitals Enterprise Ltd | 88.60 | 11.11 | 0.30% |
| Max Healthcare Institute Ltd | 50.20 | 7.48 | 0.18% |
| Fortis Healthcare Ltd | 43.13 | 3.13 | 0.30% |
Price Comparison
Compare METROPOLIS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Metropolis Healthcare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
UTI Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.6150% | Percentage of the fund’s portfolio invested in the stock 0.47% | Change in the portfolio weight of the stock over the last 3 months -0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 38/65 (0) |
Franklin India Smaller Companies Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1452% | Percentage of the fund’s portfolio invested in the stock 0.89% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/92 (+2) |
UTI AMC LTD # UTI MF-UTI MASTERSHARE UNIT SCHEME DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1076% | Percentage of the fund’s portfolio invested in the stock 0.73% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/57 (+4) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Dividend Yield
Current dividend yield is 0.54%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.45 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateFeb 23, 2023
Dividend/Share
₹8.00
Ex DateEx Date
Feb 23, 2023
Cash Dividend
Ex DateEx DateFeb 21, 2022
Dividend/Share
₹8.00
Ex DateEx Date
Feb 21, 2022
Cash Dividend
Ex DateEx DateFeb 17, 2021
Dividend/Share
₹8.00
Ex DateEx Date
Feb 17, 2021
Cash Dividend
Ex DateEx DateFeb 13, 2020
Dividend/Share
₹8.00
Ex DateEx Date
Feb 13, 2020
News & Opinions
Metropolis Healthcare Replaces Granules on F&O Ban List, 11 Stocks Held
1 month ago•Investing.com
Trade setup for Monday: Top 15 things to know before the opening bell
1 month ago•Moneycontrol
Hold Metropolis Healthcare; target of Rs 1440: ICICI Securities
1 month ago•Moneycontrol
Q1 Review: Metropolis Healthcare June Quarter Profit Misses Estimates
2 months ago•Bloomberg Quint
News Video
Q1 Review: Metropolis Healthcare Q1 Profit Misses Estimates | BQ Prime
2 months ago•BQ Prime
Metropolis Healthcare edges up despite 13.8% decline in Q1 net profit
2 months ago•Moneycontrol
Trade setup for Thursday: Top 15 things to know before the opening bell
2 months ago•Moneycontrol
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.18%, vs industry avg of 13.8%
Decreasing Market Share
Over the last 5 years, market share decreased from 2.03% to 1.86%